Pervasive Sensing and AI in Intelligent ICU

RecruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

May 24, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Critical IllnessPainDeliriumConfusion
Interventions
OTHER

Video Monitoring

continuous video monitoring

OTHER

Accelerometer Monitoring

continuous accelerometer monitoring of patient movements

OTHER

Noise Level Monitoring

continuous environmental noise monitoring

OTHER

Light Level Monitoring

continuous environmental light monitoring

OTHER

Air Quality Monitoring

continuous environmental air quality monitoring

OTHER

EKG Monitoring

continuous EKG monitoring

OTHER

Vitals Monitoring

continuous vitals monitoring (heart rate, oxygen saturation)

OTHER

Biosample Collection

blood and urine samples collected once on Day 1 and once on Day 2

OTHER

Delirium Motor Subtyping Scale 4 (DMSS-4)

done daily on delirious patients to subtype delirium

Trial Locations (1)

32610

RECRUITING

University of Florida Health Shands Hospital, Gainesville

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

National Institute for Biomedical Imaging and Bioengineering (NIBIB)

NIH

lead

University of Florida

OTHER

NCT05127265 - Pervasive Sensing and AI in Intelligent ICU | Biotech Hunter | Biotech Hunter